The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
- Publication date
- 1 January 2022
- Publisher
- 'Springer Science and Business Media LLC'